Last reviewed · How we verify

NCT05733234

Lasers in Peri-implantitis Treatment

Completed NA Last updated 17 February 2023
What this trial tests

NA trial testing Laser ,Fotona, Light Walker AT, Ljubljana, Slovenia in Peri-Implantitis in 20 participants. Completed in 21 March 2022.

Timeline
20 May 2021
Primary endpoint
21 March 2022
21 March 2022

Quick facts

Lead sponsorAristotle University Of Thessaloniki
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date20 May 2021
Primary completion21 March 2022
Estimated completion21 March 2022
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Aristotle University Of Thessaloniki

Who can join

Eligibility, male only, with Peri-Implantitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study aimed to investigate the effect of the combined Nd-Er: YAG laser on the surgical treatment of peri-implantitis by evaluating clinical markers and biomarkers of bone loss (RANKL/OPG). Twenty (20) patients having at least 1 implant diagnosed with peri-implantitis were randomly assigned to two groups for surgical treatment. In the test group (n=10), Er: YAG laser was used for granulation tissue removal and implant surface decontamination, while Nd: YAG laser was employed for deep tissue decontamination and biomodulation. In the control group (n=10), an access flap was applied, and mechanical instrumentation of the implant surface was performed by using titanium curettes. The following clinical parameters were evaluated at baseline and six months after treatment: Full-mouth Plaque Score (FMPS), Probing Pocket Depth (PPD), Probing Attachment Levels (PAL), recession (REC), and Bleeding on probing (BoP). Peri-implant crevicular fluid (PICF) was collected at baseline and six months for the evaluation of soluble RANKL and OPG utilizing enzyme-linked immunosorbent assay (ELISA).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Surgical Treatment of Peri-Implantitis Using a Combined Nd: YAG and Er: YAG Laser Approach: Investigation of Clinical and Bone Loss Biomarkers.
    Fragkioudakis I, Kallis A, Kesidou E, Damianidou O, et al · · 2023 · cited 10× · PMID 36975558 · DOI 10.3390/dj11030061

Verify or expand the search:

Other recruiting trials for Peri-Implantitis

Currently open trials in the same condition.

Other Aristotle University Of Thessaloniki trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05733234.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing